These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Oncogene-initiated aberrant signaling engenders the metastatic phenotype: synergistic transcription factor interactions are targets for cancer therapy. Denhardt DT Crit Rev Oncog; 1996; 7(3-4):261-91. PubMed ID: 9258606 [TBL] [Abstract][Full Text] [Related]
24. Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance. Sakthivel KM; Hariharan S Biomed Pharmacother; 2017 Sep; 93():1238-1245. PubMed ID: 28738540 [TBL] [Abstract][Full Text] [Related]
25. Cancer, oncogenes and signal transduction. McManus EJ; Alessi DR Genome Biol; 2004; 5(7):332. PubMed ID: 15239827 [TBL] [Abstract][Full Text] [Related]
26. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy. Yan R; Hallam A; Stockley PG; Boyes J Biochem J; 2014 Jul; 461(1):1-13. PubMed ID: 24927119 [TBL] [Abstract][Full Text] [Related]
27. [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors]. Buday L Orv Hetil; 1994 Nov; 135(47):2579-84. PubMed ID: 7824256 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases. Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209 [TBL] [Abstract][Full Text] [Related]
30. [Synthetic lethality as a new concept for the treatment of cancer]. Herter-Sprie GS; Chen S; Höpker K; Reinhardt HC Dtsch Med Wochenschr; 2011 Jul; 136(30):1526-30. PubMed ID: 21789751 [TBL] [Abstract][Full Text] [Related]
31. BIM, PUMA, and the achilles' heel of oncogene addiction. Roulston A; Muller WJ; Shore GC Sci Signal; 2013 Mar; 6(268):pe12. PubMed ID: 23532333 [TBL] [Abstract][Full Text] [Related]
32. The good oncogene: When bad genes identify good outcome in cancer. Lee JM Med Hypotheses; 2011 Feb; 76(2):259-63. PubMed ID: 21050670 [TBL] [Abstract][Full Text] [Related]
33. [Better understanding of the biology of cancer cells]. Klein G Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045 [TBL] [Abstract][Full Text] [Related]
37. Signalling pathways as targets for anticancer drug development. Powis G Pharmacol Ther; 1994; 62(1-2):57-95. PubMed ID: 7991648 [TBL] [Abstract][Full Text] [Related]
38. Integrated genomic and pharmacological approaches to identify synthetic lethal genes as cancer therapeutic targets. Mizuarai S; Irie H; Schmatz DM; Kotani H Curr Mol Med; 2008 Dec; 8(8):774-83. PubMed ID: 19075675 [TBL] [Abstract][Full Text] [Related]
39. Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment. Willis RE Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649156 [TBL] [Abstract][Full Text] [Related]